The stock of Guardant Health Inc (GH) has gone up by 2.50% for the week, with a 8.31% rise in the past month and a 84.14% rise in the past quarter. The volatility ratio for the week is 4.68%, and the volatility levels for the past 30 days are 4.96% for GH. The simple moving average for the last 20 days is 6.12% for GH’s stock, with a simple moving average of 32.16% for the last 200 days.
Is It Worth Investing in Guardant Health Inc (NASDAQ: GH) Right Now?
GH has 36-month beta value of 1.12. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GH is 115.97M, and currently, short sellers hold a 5.90% ratio of that float. The average trading volume of GH on July 26, 2024 was 2.03M shares.
GH) stock’s latest price update
The stock price of Guardant Health Inc (NASDAQ: GH) has jumped by 0.47 compared to previous close of 31.78. Despite this, the company has seen a gain of 2.50% in its stock price over the last five trading days. investorplace.com reported 2024-07-21 that Two elements favor the case for acquiring precision medicine stocks. First, the obvious point: barring extraordinary circumstances, the broader healthcare ecosystem will always be relevant.
Analysts’ Opinion of GH
Many brokerage firms have already submitted their reports for GH stocks, with Guggenheim repeating the rating for GH by listing it as a “Buy.” The predicted price for GH in the upcoming period, according to Guggenheim is $36 based on the research report published on June 28, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see GH reach a price target of $32. The rating they have provided for GH stocks is “Buy” according to the report published on June 03rd, 2024.
Craig Hallum gave a rating of “Buy” to GH, setting the target price at $28 in the report published on April 24th of the current year.
GH Trading at 11.65% from the 50-Day Moving Average
After a stumble in the market that brought GH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.24% of loss for the given period.
Volatility was left at 4.96%, however, over the last 30 days, the volatility rate increased by 4.68%, as shares surge +8.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +42.74% upper at present.
During the last 5 trading sessions, GH rose by +2.50%, which changed the moving average for the period of 200-days by +11.45% in comparison to the 20-day moving average, which settled at $30.22. In addition, Guardant Health Inc saw 18.04% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GH starting from Joyce Meghan V., who sale 100 shares at the price of $27.87 back on Jun 04 ’24. After this action, Joyce Meghan V. now owns 4,621 shares of Guardant Health Inc, valued at $2,787 using the latest closing price.
Kalia Kumud, the Chief Information Officer of Guardant Health Inc, purchase 2,187 shares at $17.82 during a trade that took place back on Mar 18 ’24, which means that Kalia Kumud is holding 12,722 shares at $38,963 based on the most recent closing price.
Stock Fundamentals for GH
Current profitability levels for the company are sitting at:
- -0.88 for the present operating margin
- 0.84 for the gross margin
The net margin for Guardant Health Inc stands at -0.76. The total capital return value is set at -0.36. Equity return is now at value -3883.89, with -28.66 for asset returns.
Based on Guardant Health Inc (GH), the company’s capital structure generated 0.94 points at debt to capital in total, while cash flow to debt ratio is standing at -0.24. The debt to equity ratio resting at 17.11. The interest coverage ratio of the stock is 205.8.
Currently, EBITDA for the company is -519.63 million with net debt to EBITDA at -0.45. When we switch over and look at the enterprise to sales, we see a ratio of 6.83. The receivables turnover for the company is 7.14for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.95.
Conclusion
To put it simply, Guardant Health Inc (GH) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
